Webinar: The barriers facing RSV vaccine launches

Never before seen insights from HCPs' online conversations

When: Available On-demand

Availability: Free for Life Sciences Companies

Speakers:

Anni Neumann, Director of Strategic Solutions, CREATION.co 

Jamie Doggett, Associate Director of Insight, CREATION.co 

In May 2023, the FDA approved the first RSV vaccine in the US for individuals 60 years of age and older, GSK’s Arexvy. Other top players such as Pfizer, Moderna, Johnson & Johnson, AstraZeneca and Sanofi are preparing to launch or investing in RSV vaccines making this a highly competitive environment.

Jamie Doggett, Associate Director of Insight, has led our award winning team of researchers to analyse the online RSV vaccination conversation from HCPs to understand their needs, opinions and behaviours in this space. 

Drawing from the fresh insights uncovered and the stakeholders involved, our Principal Consultant, Anni Neumann, will talk through the barriers to launch and consider solutions based on the importance of a customer centric omnichannel strategy.

The research will reveal:

  • The level of RSV related health stakeholder engagement online.
  • The key barriers to vaccine uptake.
  • Market specific insights for the US, EU and in emerging markets.
  • Influential online HCP voices you need to be aware of.

About CREATION.co

CREATION.co are the DOL experts with unrivalled methodologies and application experience. They have been tracking HCP digital behaviours for more than two decades and built the world’s largest healthcare professional database, CREATION Pinpoint®.


If you would like to better understand what is possible when listening to the conversations of HCPs then a 1-2-1 discussion with one of our consultants could help you plan your next steps.

Book a 1-2-1 meeting with a consultant

Frequently asked questions

A healthcare persona is a way to help identify how HCPs may think, feel and do when engaging with your healthcare organisation.

With the ability to track a variety of HCP roles including doctors, nurses, pharmacists, and allied health roles to name a few, we can classify insights specific to HCP role type allowing you to differentiate between differing beliefs and tailor communications accordingly.

 

Social media gives you a good overview of a wider audience than maybe a focused group of say 25 HCPs. It also shows you their unprompted conversations which is something that you do not get from traditional market research. Though the average age of active HCPs on social media may be in the younger bracket since these guys are “digital natives”, we are seeing pharma help their KOLs get online by partnering them with DOLs, and more of the older HCPs are begin to see the benefits of connecting to their peers online. 

HCPs are collaborating in open and closed online networks and through their conversation develop and influence opinions in these forums. These digital spaces can also be a place for you to gather intelligence, and to influence opinion.

At CREATION.co, one thing that our clients consistently tell us is that when they finally arrive at product launch, the level of activity skyrockets, and rollout can become quite frantic. So developing an understanding of your customers as early as possible will help you to pre-empt and even mitigate that.

There are three phases when thinking about effectively bringing your product to market  – pre-launch, launch year, and post-launch. This journey will take place over a number of years. The very beginning of a product’s lifecycle is arguably the most critical for your product and the area where the greatest opportunity for success usually sits.

To learn more, read our article about Pre-launch planning & DSLs – the new ways to create launch excellence in Pharma

CREATION.co can now identify where misinformation is being spread and pinpoint information gaps. Thanks to a unique global database of online HCPs combined with advanced analytics techniques, we have developed a five-step methodology to rapidly identify misinformation associated with any product or therapy area of your choice, as well as areas where information is lacking.

For more information visit our Fake news Detection page.

At CREATION.co, we can use online research to support safety signal detection and evaluation. Social media provides us with the resources required to gain drug safety profile insight, inform product decisions, and improve patient safety and experiences. We use the latest advancements in social media analysis to quickly identify safety signals relating to your product(s) and evaluate the associated context.

For more information visit our Drug Safety Monitoring page.

As our research is done from public forums when we classify each HCP in our system, we use the data they publicly share about their location. 

These insights are unprompted so you get to hear what HCPs are actually talking about among themselves. We call this direct customer intelligence. You also generally get a bigger audience than other types of market research and it is a global audience so you can see how HCPs and content from other regions are influencing the discussion. 

  • I can’t make the webinar at the scheduled time. Can I view the webinar at a later time? 

Yes, if you register for the webinar, following the live event you will receive an email with the webinar recording to view at your convenience.

 

  • What time is the webinar? What time zone is “EST”?

CREATION webinars are live streamed according to London’s time zone which is Greenwich Mean Time (GMT) during standard time and British Summer Time (BST) during Daylight Saving Time (DST), or summer time. Webinar start times are also displayed in timezones relevant to New York and Paris.

 

  • How long are CREATION.co’s webinars?

Our webinars range from 30 minutes to an hour, including time for questions and answers.

 

  • Do I need to mute myself on the webinar?

Yes, you will automatically be muted on the webinar, and will not be able to unmute yourself, to allow everyone on the call to hear the webinar clearly.

 

  • Can other people read my questions on a live webinar?

Questions shared on CREATION webinars can be submitted as private messages to the panelists and hosts. The question & answer (Q&A) feature for webinars allows attendees to privately or publicly ask questions during the webinar, for the panelists, and hosts to answer.

 

  • How do I get in touch with the webinar speakers?

To get in touch with the webinar speakers you can email us at [email protected] and our team will connect you with the respective speaker. During the webinar the speaker will also likely include their contact or LinkedIn details.

 

  • Can I share the webinar recording link? 

Yes, currently our webinar recording links can be shared with fellow pharma colleagues however, we would ask they are not shared with agencies or those unable to register for the webinar.

 

  • Who do I contact if the link to the webinar is not working?

If your link is not working, or you have any issue accessing the live or recorded webinar you can email us at [email protected] and we will help you as soon as possible.

 

  • Can you run an internal webinar for my company only?

Yes, we regularly run webinars focused on a specific pharmaceutical company and their particular business objectives, often partnering with an employee from that organisation. 

 

  • What platform do you run your webinars on?

CREATION webinars are currently run on Zoom. If you are unable to use Zoom due to a company policy or firewall please email us at [email protected] and we can arrange a presentation of the webinar on Microsoft Teams or an available platform.

 

  • Do you share client work in your webinars?

In our webinars we share bespoke research, and anonymised case studies of our client work due to our work with global pharmaceutical companies being under strict NDA agreements.

 

  • I would like to learn more about another topic within the type of work you do. Can I recommend a future webinar topic?

Yes, we would be happy to hear from you about any suggestions you may have regarding future webinar topics.

Frequently asked questions

Yes, we would be happy to hear from you about any suggestions you may have regarding future webinar topics.

In our webinars we share bespoke research, and anonymised case studies of our client work due to our work with global pharmaceutical companies being under strict NDA agreements.

CREATION webinars are currently run on Zoom. If you are unable to use Zoom due to a company policy or firewall please email us at [email protected] and we can arrange a presentation of the webinar on Microsoft Teams or an available platform.

Yes, we regularly run webinars focused on a specific pharmaceutical company and their particular business objectives, often partnering with an employee from that organisation.

If your link is not working, or you have any issue accessing the live or recorded webinar you can email us at [email protected] and we will help you as soon as possible.

Yes, currently our webinar recording links can be shared with fellow pharma colleagues however, we would ask they are not shared with agencies or those unable to register for the webinar.

To get in touch with the webinar speakers you can email us at [email protected] and our team will connect you with the respective speaker. During the webinar the speaker will also likely include their contact or LinkedIn details.

Questions shared on CREATION webinars can be submitted as private messages to the panellists and hosts. The question & answer (Q&A) feature for webinars allows attendees to privately or publicly ask questions during the webinar, for the panellists, and hosts to answer.

Yes, you will automatically be muted on the webinar, and will not be able to unmute yourself, to allow everyone on the call to hear the webinar clearly.